Cg Oncology Inc. Earnings

Cg Oncology Inc.’s revenue jumped 45500% since last year same period to $0.46Mn in the Q4 2024. On a quarterly growth basis, Cg Oncology Inc. has generated 960.47% jump in its revenue since last 3-months.

Cg Oncology Inc.’s net profit fell -97.31% since last year same period to $-31.8Mn in the Q4 2024. On a quarterly growth basis, Cg Oncology Inc. has generated -55.83% fall in its net profits since last 3-months.

Cg Oncology Inc.’s net profit margin jumped 99.57% since last year same period to -6973.25% in the Q4 2024. On a quarterly growth basis, Cg Oncology Inc. has generated 85.31% jump in its net profit margins since last 3-months.

Cg Oncology Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.46 - a -35.06% fall from last quarter’s estimates.

Cg Oncology Inc.’s earning per share (EPS) estimates for the current year stand at -0.46.

Cg Oncology Inc.’s earning per share (EPS) fell -45.06% since last year same period to -0.48 in the Q4 2024. This indicates that the Cg Oncology Inc. has generated -45.06% annual rate of fall in its earning per share (EPS) in the last 4 quarters.